Ruxolitinib Impurity 65 | CAS 2102675-45-4 - Request Quote
Ruxolitinib Impurity 65
| SZ CAT No: | SZ-R044097 |
| CAS No | 2102675-45-4 |
| Mol.F. | C8H14N2O |
| Mol.Wt. | 154.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ruxolitinib Impurity 65 is chemically (S)-5-Cyclopentylpyrazolidin-3-one. Ruxolitinib Impurity 65 is supplied with detailed characterization data compliant with regulatory guideline. Ruxolitinib Impurity 65 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ruxolitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2102675-45-4
Purchase 2102675-45-4
Order 2102675-45-4
Enquire 2102675-45-4
price of 2102675-45-4
2102675-45-4 Supplier
2102675-45-4 Manufacturer
2102675-45-4 Exporter
buy high quality Ruxolitinib Impurity 65
Purchase Ruxolitinib Impurity 65
Ruxolitinib Impurity 65 suppliers
Ruxolitinib Impurity 65 manufacturers
Ruxolitinib Impurity 65 price
Order Ruxolitinib Impurity 65
Enquire Ruxolitinib Impurity 65
Ruxolitinib Impurity 65 cost
Ruxolitinib Impurity 65 Supplier
Ruxolitinib Impurity 65 Distributor
Ruxolitinib Impurity 65 for Method Validation
Ruxolitinib Reference Standard
Ruxolitinib Impurity 65 for ANDA Filing
Ruxolitinib Impurity 65 for Forced Degradation Studies
Ruxolitinib Impurity 65 Identification Standards
Ruxolitinib Impurity 65 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.